The main market opportunities lie in developing comprehensive training and support services for implementing and integrating clinical quality management systems (CQMS) that align with evolving ...
The market opportunity lies in providing training and tools for EU RMP compliance, focusing on creating and updating RMPs per regulatory standards. Key services include offering practical guidance on ...
Recent guidance from regulators emphasizes bioassays and potency assurance strategies, underscoring the robustness of these ...
Press Release Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026All clinical trial and ...
Union Minister and BJP National President JP Nadda visits the Mall Road area and the Indian Coffee House (ICH) in Shimla.
Clinical Trials Arena on MSN

AI takes charge of data, but challenges linger

At CDMI Europe 2025, experts agreed that AI is the key technology to improve efficiencies in clinical trial data management.
Diwali is the 16th Indian element to be inscribed on UNESCO's Intangible Cultural Heritage list. The list now features around 700 elements, including 16 from India ...
ABSTRACT: Nitrosamine Drug Substance Related Impurities (NDSRIs) are commonly examined using High Performance Liquid Chromatography (HPLC) in combination with Mass Spectrometry (MS) detection. Due to ...
This long-awaited guideline will revolutionise clinical trial management across life sciences, giving CGT developers a regulatory framework that finally matches the speed and flexibility their ...
ABSTRACT: For the identification of the seven Nitrosamine Impurities i.e. N-Methyl-N-Nitrosopropane-1,3-diamine (Nitroso MAPA), N-Nitrosomethyl phenylamine (NMPA), N-Nitrosoethylisopropylamine (NEIPA) ...
CITI Program updates GCP curriculum and launches new course in response to ICH E6(R3) to support clinical trial compliance and training. Our updated GCP curriculum ensures that sponsors, investigators ...